| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Allulose | D-Allulose | VL5830001 | View |
Allulose Related Compound
It is a bioactive, rare glucose epimer that inhibits the development of cancer cells by activating a tumor suppressor gene that works with thioredoxin.
References
- “Sugar-Free Sweetener: Allulose | Type2Diabetes.com.” Type2Diabetes.com, 2021, type2diabetes.com/nutrition/allulose. Accessed 8 Feb. 2023.
- Han, Youngji, et al. “Anti-Diabetic Effects of Allulose in Diet-Induced Obese Mice via Regulation of MRNA Expression and Alteration of the Microbiome Composition.” Nutrients, vol. 12, no. 7, July 2020, p. 2113, https://doi.org/10.3390/nu12072113. Accessed 8 Feb. 2023.
FAQ’s
What are the therapeutic benefits of allulose?
Allulose may effectively protect the insulin-producing pancreatic beta cells, reduce blood sugar levels, and improve insulin sensitivity.
Is allulose beneficial for Type 2 diabetics?
For those with type 2 diabetes, allulose is a safe sugar-free sweetener to use. This sweetener has no impact on blood sugar levels and has a naturally low calorie and carbohydrate content.
Does allulose cause insulin resistance?
Allulose Reduced Insulin Resistance and Glucose Tolerance in DIO Mice by Modulating the Activities of Hepatic Glucose-Regulating Enzymes. Beginning in week 4, the ALL group’s FBG and plasma insulin concentrations were significantly lower than the HFD group’s .
